• Purdue as national counsel in lawsuits in a federal MDL and in state courts across the country concerning its prescription opioid pain medications, including OxyContin.
    • A manufacturing company in product liability litigation involving allegations that a product sold to the military is related to hearing loss suffered by servicemen and women.
    • AbbVie in national product liability litigation related to its product Androgel, a testosterone replacement therapy. This litigation comprises an MDL in Chicago and additional cases in state courts in Mississippi, Illinois, Pennsylvania and Missouri.
    • Getinge AB and Atrium Medical Corporation in more than 2,400 personal injury lawsuits that have been filed involving their hernia mesh products, including an MDL in New Hampshire.
    • GlaxoSmithKline as lead national counsel to in an ongoing MDL in the Southern District of Florida concerning the FDA’s market withdrawal of Zantac, an antacid medication.
    • Pfizer as national coordinating counsel in the Lipitor MDL, where 3,000+ plaintiffs alleged that a cholesterol-lowering medication caused them to develop Type 2 diabetes. Dechert’s Daubert strategy led to exclusion of plaintiffs’ experts on general causation grounds and the granting of summary judgment in all cases in the MDL. The Fourth Circuit unanimously affirmed. Dechert subsequently obtained a similar victory in California Superior Court after the product was spun off from Pfizer to Viatris.
    • American Bar Association
    • Defense Research Institute